MannKind Killed After Earnings (MNKD) - MannKind (NASDAQ:MNKD)

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.

Mannkind (NASDAQ: MNKD), whose AFREZZA insulin delivery device was recently rejected by the FDA, released its quarterly earnings after the closing bell on Thursday. The company reported a loss of $0.33 per share versus analysts' estimates which called for a loss of $0.40 per share. In the year ago period, MNKD lost $0.53. During Friday's trading session, the stock has been obliterated, losing more than 25% to $3.81. Volume is running at around 15 million shares compared to a daily average of 5 million. MNKD is a wounded company at this point, having lost around 56% in the last month.

Crypto Whales Are Loading Up — Are You?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!